Binding affinities at I-1 and I-2 Imidazoline Binding Sites (IBS) of a number of properly substituted imidazoline, oxazoline and pyrroline ligands were studied through an integrated modelling approach based on a coordinated application of 2D- (MGZ) and 3D-QSAR (CoMFA-and GRID-GOLPE) analyses and on the development of a quantitative pharmacophore (HypoGen). Congruent and significant cross-validated 2D and 3D correlations, having promising predictive ability, indicated that electrostatic and steric interactions differently modulate the binding affinities at I-1/I-2 IBS. Stereoselective interactions of chiral alpha or beta substituted imidazolines, leading to diverse I-1/I-2 binding affinities and selectivities, were correctly predicted by the models. Slightly different pharmacophore features were detected by means of Hypogen for I-1 and I-2-IBS ligands.

Pharmacophore Development and 3D-QSAR Study of I1 Imidazoline Binding Site Ligands / O., Nicolotti; A., Carotti; A., Carrieri; M., Pigini; F., Gentili; Brasili, Livio; M., Giannella; W., Quaglia; A., Piergentili; P., Bousquet; M., Dontenwill. - In: MEDICINAL CHEMISTRY RESEARCH. - ISSN 1054-2523. - STAMPA. - 13:(2004), pp. 170-189.

Pharmacophore Development and 3D-QSAR Study of I1 Imidazoline Binding Site Ligands

BRASILI, Livio;
2004

Abstract

Binding affinities at I-1 and I-2 Imidazoline Binding Sites (IBS) of a number of properly substituted imidazoline, oxazoline and pyrroline ligands were studied through an integrated modelling approach based on a coordinated application of 2D- (MGZ) and 3D-QSAR (CoMFA-and GRID-GOLPE) analyses and on the development of a quantitative pharmacophore (HypoGen). Congruent and significant cross-validated 2D and 3D correlations, having promising predictive ability, indicated that electrostatic and steric interactions differently modulate the binding affinities at I-1/I-2 IBS. Stereoselective interactions of chiral alpha or beta substituted imidazolines, leading to diverse I-1/I-2 binding affinities and selectivities, were correctly predicted by the models. Slightly different pharmacophore features were detected by means of Hypogen for I-1 and I-2-IBS ligands.
2004
13
170
189
Pharmacophore Development and 3D-QSAR Study of I1 Imidazoline Binding Site Ligands / O., Nicolotti; A., Carotti; A., Carrieri; M., Pigini; F., Gentili; Brasili, Livio; M., Giannella; W., Quaglia; A., Piergentili; P., Bousquet; M., Dontenwill. - In: MEDICINAL CHEMISTRY RESEARCH. - ISSN 1054-2523. - STAMPA. - 13:(2004), pp. 170-189.
O., Nicolotti; A., Carotti; A., Carrieri; M., Pigini; F., Gentili; Brasili, Livio; M., Giannella; W., Quaglia; A., Piergentili; P., Bousquet; M., Dontenwill
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/303444
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 5
social impact